CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 51 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.08 and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,385,292 | +4.5% | 832,348 | 0.0% | 0.00% | +50.0% |
| Q2 2023 | $5,152,234 | +60.8% | 832,348 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,204,540 | +24.2% | 832,348 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $2,580,279 | -22.9% | 832,348 | -0.1% | 0.00% | -50.0% |
| Q3 2022 | $3,348,000 | -17.5% | 832,932 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $4,056,000 | -26.7% | 832,932 | +35.0% | 0.00% | 0.0% |
| Q1 2022 | $5,534,000 | -14.6% | 616,903 | +7.2% | 0.00% | 0.0% |
| Q4 2021 | $6,480,000 | -57.9% | 575,538 | -37.6% | 0.00% | -66.7% |
| Q3 2021 | $15,399,000 | -24.9% | 922,100 | -0.1% | 0.01% | -25.0% |
| Q2 2021 | $20,493,000 | – | 922,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Index Venture Life Associates VI Ltd | 9,961,789 | $112,170,000 | 100.00% |
| Medicxi Ventures Management (Jersey) Ltd | 18,123,892 | $204,075,000 | 51.07% |
| Vida Ventures Advisors, LLC | 3,931,818 | $44,272,000 | 16.56% |
| OUP Management Co., LLC | 2,341,891 | $26,370,000 | 11.89% |
| Samsara BioCapital, LLC | 1,459,693 | $16,436,000 | 3.19% |
| VR Adviser, LLC | 1,127,272 | $12,693,000 | 1.74% |
| Affinity Asset Advisors, LLC | 419,144 | $4,720,000 | 1.71% |
| Cormorant Asset Management, LP | 2,489,894 | $28,036,000 | 1.67% |
| Kynam Capital Management, LP | 239,041 | $2,692,000 | 1.44% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $109,017,000 | 0.84% |